2 years ago
VKTX
AnalystsJay OlsonJay Olson's Stock Forecasts
AnalystsJay Olson
Analyst Ranking
Top 3%
#155 out of 5272 analysts
Average Return
+22.74%
Win Rate
46%107 out of 233
Risk vs Reward
Poor
Good
Jay Olson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +728.78% | $39.82 | $330.02 | 2025-06-01 - 2026-05-08 | Buy |
Praxis Precision Medicines IncPRAX | +605.77% | $46.76 | $330.02 | 2025-07-07 - 2026-05-08 | Buy |
89bio IncETNB | +578.03% | $2.64 | $17.90 | 2022-05-12 - 2023-05-12 | Buy |
Terns Pharmaceuticals IncTERN | +550.49% | $8.14 | $52.95 | 2025-10-21 - 2026-05-04 | Buy |
89bio IncETNB | +450.31% | $3.22 | $17.72 | 2022-06-29 - 2023-06-29 | Buy |
Jay Olson Analyst Color
Get additional color on Jay Olson's coverage of popular stocks
2 years ago
VKTX
2 years ago
VKTX
3 years ago
VKTX
Jay Olson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 11 | Hold | $90.00 | -8.69% | Maintains | 11 days ago |
Passage Bio IncPASG | 2 | Buy | $15.00 | +256.29% | Maintains | 19 days ago |
Revolution Medicines IncRVMD | 11 | Buy | $165.00 | +16.35% | Maintains | a month ago |
Biogen IncBIIB | 22 | Buy | $275.00 | +42.16% | Maintains | a month ago |
Bicycle Therapeutics PLCBCYC | 5 | Buy | $36.00 | +648.44% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 2 | Buy | $600.00 | +39.59% | Maintains | 2 months ago |
Bioage Labs IncBIOA | 1 | Buy | $60.00 | +233.52% | Initiates Coverage On | 3 months ago |
Acadia Pharmaceuticals IncACAD | 13 | Hold | $23.00 | +2.68% | Maintains | 3 months ago |
Coherus Oncology IncCHRS | 1 | Buy | $10.00 | +471.43% | Initiates Coverage On | 4 months ago |
Praxis Precision Medicines IncPRAX | 3 | Buy | $750.00 | +127.26% | Maintains | 5 months ago |
Terns Pharmaceuticals IncTERN | 4 | Buy | $58.00 | +9.54% | Maintains | 5 months ago |
Madrigal Pharmaceuticals IncMDGL | 10 | Buy | $650.00 | +27.44% | Maintains | 6 months ago |
Ibio IncIBIO | 1 | Buy | $5.00 | +192.40% | Initiates Coverage On | 7 months ago |
Ionis Pharmaceuticals IncIONS | 4 | Buy | $90.00 | +19.28% | Maintains | 7 months ago |
Immuneering CorpIMRX | 3 | Buy | $30.00 | +474.71% | Maintains | 8 months ago |
Definium Therapeutics IncDFTX | 1 | Buy | $25.00 | +13.38% | Reinstates | 9 months ago |
Ataibeckley IncATAI | 1 | Buy | $14.00 | +247.39% | Initiates Coverage On | 9 months ago |
Tvardi Therapeutics IncTVRD | 1 | Buy | $65.00 | +1,455.02% | Initiates Coverage On | a year ago |
Jasper Therapeutics IncJSPR | 5 | Buy | $65.00 | +6,919.44% | Maintains | a year ago |
Inovio Pharmaceuticals IncINO | 3 | Buy | $13.00 | +790.41% | Maintains | a year ago |
Nektar TherapeuticsNKTR | 6 | Buy | $90.00 | N/A | Upgrades | a year ago |
Denali Therapeutics IncDNLI | 4 | Buy | $42.00 | N/A | Maintains | a year ago |
Prothena Corp Public Ltd CoPRTA | 11 | Buy | $62.00 | N/A | Maintains | a year ago |
Exelixis IncEXEL | 6 | Hold | $33.00 | N/A | Downgrades | a year ago |
Intellia Therapeutics IncNTLA | 9 | Buy | $40.00 | N/A | Maintains | a year ago |
Q32 Bio IncQTTB | 2 | Buy | $20.00 | N/A | Maintains | a year ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $30.00 | N/A | Initiates Coverage On | a year ago |
Sage Therapeutics IncSAGE | 7 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Damora Therapeutics IncDMRA | 4 | Buy | $10.00 | N/A | Maintains | 2 years ago |
Viking Therapeutics IncVKTX | 8 | Buy | $138.00 | N/A | Reiterates | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 6 | Buy | $6.00 | N/A | Upgrades | 2 years ago |
Gain Therapeutics IncGANX | 1 | Buy | $8.00 | N/A | Assumes | 2 years ago |
Amgen IncAMGN | 17 | Buy | $380.00 | N/A | Maintains | 2 years ago |
Neurocrine Biosciences IncNBIX | 12 | Buy | $219.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 6 | Hold | $12.00 | N/A | Maintains | 2 years ago |
Voyager Therapeutics IncVYGR | 5 | Buy | $18.00 | N/A | Maintains | 2 years ago |
Sutro Biopharma IncSTRO | 5 | Buy | $100.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 6 | Buy | $95.00 | N/A | Maintains | 2 years ago |
Skye Bioscience IncSKYE | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Cognition Therapeutics IncCGTX | 4 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Biovie IncBIVI | 4 | Buy | $500.00 | N/A | Maintains | 2 years ago |
Enanta Pharmaceuticals IncENTA | 7 | Hold | $21.00 | N/A | Maintains | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 3 years ago |
Mirati Therapeutics IncMRTX | 7 | Buy | $62.00 | N/A | Maintains | 3 years ago |
Cymabay Therapeutics IncCBAY | 3 | Buy | $16.00 | N/A | Maintains | 3 years ago |
89bio IncETNB | 4 | Buy | $30.00 | N/A | Reiterates | 3 years ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $280.00 | N/A | Reiterates | 3 years ago |
Seagen IncSGEN | 8 | Buy | $229.00 | N/A | Maintains | 3 years ago |
Cincor Pharma IncCINC | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Ayala Pharmaceuticals IncAYLA | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Relmada Therapeutics IncRLMD | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Sierra Oncology IncSRRA | 2 | Hold | $55.00 | N/A | Downgrades | 4 years ago |
Focus Financial Partners IncFOCS | 1 | Buy | $71.00 | N/A | Maintains | 5 years ago |
Korro Bio IncKRRO | 2 | Buy | $20.00 | N/A | Maintains | 5 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Hold | $46.00 | N/A | Downgrades | 6 years ago |
Tempest Therapeutics IncTPST | 1 | Hold | $2.00 | N/A | Downgrades | 6 years ago |
Mediwound LtdMDWD | 1 | Buy | $84.00 | N/A | Maintains | 8 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $2,520.00 | N/A | Maintains | 8 years ago |
Medicines CoMDCO | 2 | Buy | N/A | N/A | Upgrades | 8 years ago |
Neuroderm LtdNDRM | 2 | Buy | $42.00 | N/A | Upgrades | 9 years ago |
Therapeuticsmd IncTXMD | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.